Ingredient
Methyl Benzodioxepinone
Methyl Benzodioxepinone is flagged for pregnancy, breastfeeding, trying to conceive and PCOS. The concern behind the strongest flag is endocrine disruptor and absorbed into the body.
- Methylbenzodioxepinone
- Galaxolide-like compound
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Methyl Benzodioxepinone and pregnancy
Caution Advised
- Endocrine disruptor
- Absorbed into the body
Methyl benzodioxepinone is a synthetic fragrance compound used to provide musky scents in cosmetic products. It belongs to a class of polycyclic musk compounds that have raised concerns due to their lipophilic (fat-soluble) nature and potential for bioaccumulation. Some synthetic musk compounds have demonstrated endocrine-disrupting properties in laboratory studies and can cross the placental barrier. While specific pregnancy studies on methyl benzodioxepinone are lacking, its structural similarity to other synthetic musks that have been detected in umbilical cord blood raises theoretical concerns. The European Commission's Scientific Committee has expressed concern about the bioaccumulation potential and endocrine activity of certain synthetic musks. Due to limited safety data specific to pregnancy and the potential for endocrine disruption based on chemical structure, pregnant women may choose to minimize exposure to synthetic fragrance compounds, particularly those in the polycyclic musk family. Fragrance-free or naturally-scented alternatives may be preferable during pregnancy.
Methyl Benzodioxepinone and breastfeeding
Caution Advised
- Passes into breast milk
Methyl benzodioxepinone is a fat-soluble synthetic fragrance compound. Studies on similar polycyclic musk compounds have detected their presence in human breast milk, indicating that these substances can accumulate in fatty tissues and transfer to breastfed infants. The fat-soluble nature of synthetic musks means they can potentially concentrate in breast milk over time with repeated exposure. While direct evidence of harm to infants is limited, the detection of these compounds in breast milk and their persistence in the body raises caution among toxicologists and pediatric health experts. Given the potential for transfer to breast milk and the vulnerability of developing infants to endocrine-disrupting compounds, breastfeeding women may prefer to minimize exposure to synthetic musk fragrances. Choosing fragrance-free or naturally-scented products can reduce this theoretical risk.
Methyl Benzodioxepinone and postpartum
Safe to Use
For postpartum women not breastfeeding, the primary concerns related to synthetic musks (transfer to infant via breast milk) are not applicable. The ingredient can be used according to general cosmetic safety guidelines. While synthetic musks have environmental and potential endocrine concerns, postpartum women not breastfeeding face no specific additional risks from topical cosmetic use of methyl benzodioxepinone compared to the general population.
Methyl Benzodioxepinone and trying to conceive
Caution Advised
- Endocrine disruptor
- Builds up in tissue
Synthetic musk compounds like methyl benzodioxepinone are fat-soluble and can accumulate in body tissues over time. For women trying to conceive, minimizing exposure to potential endocrine disruptors is often recommended by reproductive health specialists. While direct evidence linking this compound to fertility issues is limited, its structural similarity to other synthetic musks that have shown endocrine activity raises theoretical concerns. Women planning pregnancy may choose to transition away from products containing synthetic fragrances as a precautionary measure to reduce body burden before conception.
Methyl Benzodioxepinone and PCOS
Caution Advised
- Endocrine disruptor
- Interferes with hormones
Methyl benzodioxepinone belongs to a class of synthetic fragrance compounds that have demonstrated potential endocrine-disrupting properties in laboratory studies. For women with PCOS, who already experience hormonal imbalances, minimizing exposure to endocrine disruptors is often recommended. While direct evidence linking this specific synthetic musk to worsening PCOS symptoms is lacking, the general concern about endocrine-disrupting chemicals affecting hormone-sensitive conditions applies. Some synthetic musks have shown estrogenic or anti-androgenic activity in studies, which could theoretically interfere with hormonal management in PCOS. Women with PCOS may benefit from reducing exposure to synthetic fragrance compounds, particularly those with potential endocrine activity. Choosing fragrance-free products or those scented with natural extracts may be a precautionary approach for managing hormonal health.
Methyl Benzodioxepinone and general use
Safe to Use
- Endocrine disruptor
- Environmental pollutant
Methyl benzodioxepinone is a synthetic fragrance compound used to provide musky scents in cosmetics and personal care products. It is part of the polycyclic musk family, which has been studied for potential environmental and health impacts. The primary concerns with synthetic musk compounds relate to their persistence in the environment, bioaccumulation potential, and possible endocrine-disrupting properties demonstrated in some laboratory studies. These compounds have been detected in human tissues, including blood and fat, indicating systemic absorption and retention. However, current evidence does not establish clear adverse health effects at typical cosmetic exposure levels for the general population. The ingredient is approved for use in cosmetics in the EU and US, though some related synthetic musks have been restricted or phased out due to environmental concerns. Individuals concerned about synthetic fragrance chemicals may opt for fragrance-free or naturally-scented alternatives.
Everything else flagged for the same profiles
Related ingredients
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store